drugset / Trial / NCT01317199
Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer
Phase 1/2
Completed
143 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Howard University · collabProstate Cancer Clinical Trials Consortium · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This research is being done to test an investigational product called Muscadine Plus in the treatment of men who have received initial therapy (surgery and or radiation, cryotherapy or brachytherapy) for prostate cancer and are experiencing a rise in their prostate-specific antigens (PSA) level.
Timeline
- Start
- 2011-07
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Muscadine Plus Grape Skin Extract | Unknown | 500 mg | Oral |
| Subject | Muscadine Plus Grape Skin Extract | Unknown | 4000 mg | Oral |